Genexis raised ₹4 crore from GVFL, intending to scale recombinant protein manufacturing products. It is committed to closing the gap between the manufacturing of animal-origin-free products and scaling production to meet industry demand, such as healthcare, food, and pharma companies. GVFL also found the strategic opportunity to finance the innovative biotech formulations.